Palisade Bio (PALI) Payables (2010 - 2026)

Palisade Bio (PALI) has 17 years of Payables data on file, last reported at $2.7 million in Q1 2026.

• On a quarterly basis, Payables rose 261.88% year-over-year to $2.7 million in Q1 2026; TTM through Mar 2026 was $2.7 million, a 261.88% increase from a year earlier, with the FY2025 full-year figure at $767000.0, down 30.59% from the prior year.
• Payables for Q1 2026 stood at $2.7 million, up from $767000.0 in the prior quarter.
• Over the last five years, Payables for PALI reached as high as $2.7 million in Q1 2026 and fell as low as $366000.0 in Q3 2024.
• Historically, Payables has averaged $1.1 million across 5 years, with a median of $950000.0 in 2023.
• Across the five-year window, Payables slumped 61.47% in 2024 and jumped 289.62% in 2025, its largest moves.
• Year by year, Payables stood at $1.8 million in 2022, then sank by 60.32% to $698000.0 in 2023, then soared by 58.31% to $1.1 million in 2024, then tumbled by 30.59% to $767000.0 in 2025, then surged by 251.5% to $2.7 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $2.7 million in Q1 2026, $767000.0 in Q4 2025, and $1.4 million in Q3 2025.